Medicine Pissurno NSCA, Lichs GGC et. al.
Aug 5th, 2020 - A sudden onset of anosmia has been recently recognized as a symptom of coronavirus disease (COVID-19). Here, we describe a case of complete anosmia in a young male with COVID-19. Although he had fever and odynophagia, no abnormalities were observed in his nasopharyngeal mucosa, suggesting that his anosmia resulted from olfactory neuropathy. COVID-19 was confirmed by RNA detection in nasopharyng...
Mayo Clinic Proceedings; Agyeman AA, Chin KL et. al.
Aug 5th, 2020 - To estimate the prevalence of olfactory and gustatory dysfunctions (OGDs) among patients infected with novel coronavirus disease 2019 (COVID-19). A systematic review was conducted by searching MEDLINE, EMBASE, and the preprint server MedRxiv from their inception until May 11, 2020, using the terms anosmia or hyposmia or dysosmia or olfactory dysfunction or olfaction disorder or smell dysfunctio...
Headache References; Poncet-Megemont L, Paris P et. al.
Aug 4th, 2020 - To document the prevalence of new headaches in patients with Covid-19 infection and the potential association with other neuro-sensorial symptoms (anosmia and ageusia). The persistence of these symptoms 1 month after recovery was also documented. Headaches are a very common symptom of viral infections. Surprisingly, early Chinese studies reported a relatively low prevalence (12-15%) of headache...
Southern Medical Journal; Iran-Pour E, Tavabi AA et. al.
Aug 3rd, 2020 - Presentation with Anosmia and Ageusia: Possible Hidden Carriers of COVID-19.|2020|Iran-Pour E,Tavabi AA,Seifi A,|
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery; Rocke J, Hopkins C et. al.
Aug 2nd, 2020 - 1. To systematically review the currently available evidence investigating the association between olfactory dysfunction (OD) and the novel coronavirus (COVID-19). 2. To analyse the prevalence of OD in patients who have tested positive on Polymerase Chain Reaction (PCR) for COVID-19. 2. To perform a meta-analysis of patients presenting with olfactory dysfunction, during the pandemic, and to inv...
The Journal of Headache and Pain; Trigo J, García-Azorín D et. al.
Jul 30th, 2020 - Headache is one of the most frequent neurologic manifestations in COVID-19. We aimed to analyze which symptoms and laboratory abnormalities were associated with the presence of headache and to evaluate if patients with headache had a higher adjusted in-hospital risk of mortality. Retrospective cohort study. We included all consecutive patients admitted to the Hospital with confirmed SARS-CoV-2 ...
Clinical and Experimental Medicine; Gavriatopoulou M, Korompoki E et. al.
Jul 28th, 2020 - Although COVID-19 presents primarily as a lower respiratory tract infection transmitted via air droplets, increasing data suggest multiorgan involvement in patients that are infected. This systemic involvement is postulated to be mainly related to the SARS-CoV-2 virus binding on angiotensin-converting enzyme 2 (ACE2) receptors located on several different human cells. Lung involvement is the mo...
Clinical Imaging; Doo FX, Kassim G et. al.
Jul 24th, 2020 - Coronavirus disease 2019 (COVID-19) is a global pandemic, and it is increasingly important that physicians recognize and understand its atypical presentations. Neurological symptoms such as anosmia, altered mental status, headache, and myalgias may arise due to direct injury to the nervous system or by indirectly precipitating coagulopathies. We present the first COVID-19 related cases of carot...
International Journal of Molecular Medicine; Kerslake R, Hall M et. al.
Jul 24th, 2020 - Severe acute respiratory syndrome (SARS) coronavirus‑2 (SARS‑CoV‑2) enters into human host cells via mechanisms facilitated mostly by angiotensin‑converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2). New loss of smell (anosmia/hyposmia) is now recognized as a COVID‑19 related symptom, which may be caused by SARS‑CoV‑2 infection and damage of the olfactory receptor (OR) cells...
Journal of Medical Virology; Maggiolo F, Zoboli F et. al.
Jul 24th, 2020 - Information about SARS-CoV-2 infection in HIV-infected individuals is scarce. In this prospective study, we included HIV-infected individuals (PLWHIV) with confirmed SARS-CoV-2 infection and compared them with PLWHIV negative for SARS-CoV-2. we compared 55 cases of SARS-CoV-2 infection with 69 asymptomatic PLWHIV negative for SARS-CoV-2 RT-PCR and/or serology. There was no significant differenc...
International Journal of Environmental Research and Public Health; Magnavita N, Tripepi G et. al.
Jul 23rd, 2020 - In March-April 2020, the Corona Virus Disease 19 (COVID-19) pandemic suddenly hit Italian healthcare facilities and in some of them many staff members became infected. In this work 595 health care workers from a public company were tested for Severe acute respiratory syndrome coronavirus 2 (82 positive) and asked to complete a questionnaire on early COVID-19 symptoms. Respiratory symptoms were ...
BMJ (Clinical Research Ed.); Walker A, Pottinger G et. al.
Jul 22nd, 2020 - Anosmia and loss of smell in the era of covid-19.|2020|Walker A,Pottinger G,Scott A,Hopkins C,|complications,diagnosis,diagnosis,etiology,therapy,complications,diagnosis,
Multiple Sclerosis and Related Disorders; Palao M, Fernández-Díaz E et. al.
Jul 22nd, 2020 - SARS-CoV-2 infection can produce neurological features. The most common are headache, anosmia and dysgeusia but patients may also develop other central nervous system (CNS) injuries. We present a patient affected by Covid-19 who initially consulted for decreased visual acuity. The MRI showed inflammation in the right optic nerve and demyelinating lesions in the CNS. We speculate that an immune ...
Clinical Immunology (Orlando, Fla.); Gasmi A, Tippairote T et. al.
Jul 21st, 2020 - COVID-19 rapidly turned to a global pandemic posing lethal threats to overwhelming health care capabilities, despite its relatively low mortality rate. The clinical respiratory symptoms include dry cough, fever, anosmia, breathing difficulties, and subsequent respiratory failure. No known cure is available for COVID-19. Apart from the anti-viral strategy, the supports of immune effectors and mo...
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association; Divani AA, Andalib S et. al.
Jul 21st, 2020 - Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health threat. Some COVID-19 patients have exhibited widespread neurological manifestations including stroke. Acute ischemic stroke, intracerebral hemorrhage, and cerebral venous sinus thrombosis have been reported in patients with COVID-19. COVID-19-associated coagulopat...
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP); Negri E, La Vecchia C
Jul 21st, 2020 - A survey was conducted through a web link on the students and staff of the Università degli Studi di Milano, Italy in the period 14-30 April 2020. It was anonymous at the source and included history of COVID-19-related questions (fever, headache, cold, cough, anosmia, gastrointestinal complaints and separately fever over 38.5°C) in the previous three weeks, and similar information on cohabitant...
AIDS Research and Human Retroviruses; Al-Harthi L, Campbell EM et. al.
Jul 18th, 2020 - Severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) is the etiologic agent of COVID-19, a disease that as of July 10, 2020, has infected over 12 million people and killed over 500,000. COVID-19 infection leads to Acute Respiratory Distress Syndrome (ARDS) in a subset of patients and is a primary driver of acute morbidity in infected persons. However, it is becoming increasingly clear ...
The Laryngoscope; Lechien JR, Michel J et. al.
Jul 17th, 2020 - To investigate clinical and radiological features of olfactory clefts of patients with mild coronavirus disease 2019 (COVID-19). Sixteen COVID-19 patients were recruited. The epidemiological and clinical data were extracted. Nasal complaints were assessed through the sino-nasal outcome test 22 (SNOT-22). Patients underwent psychophysical olfactory testing, olfactory cleft examination and CT-sca...
Expert Review of Anti-infective Therapy; Cherry G, Rocke J et. al.
Jul 16th, 2020 - It has been demonstrated that reduction in smell and/or taste is the most predictive symptom in SARS-CoV-2/Covid-19 infection. We used Google Trends to analyze regional searches relating to loss of smell and taste across Italy, Spain, France, Brazil, and the United States of America and determined the association with reported Covid-19 cases. In order to retrieve the data, we built a Python sof...
Journal of Medical Virology; Pouga L
Jul 16th, 2020 - Since the discovery of COVID-19, a disease caused by the new coronavirus SARS-CoV-2, the pathology showed different faces. There is an increasing number of cases described as (meningo)encephalitis although evidence often lacks. Anosmia, another atypical form of COVID-19, has been considered as testimony of the potential of neuroinvasiveness of SARS-CoV-2, though this hypothesis remains highly s...